Paul R. Johnston Sells 1,300 Shares of Exponent, Inc. (NASDAQ:EXPO) Stock

Exponent, Inc. (NASDAQ:EXPO) Director Paul R. Johnston sold 1,300 shares of the stock in a transaction dated Wednesday, November 20th. The stock was sold at an average price of $95.03, for a total transaction of $123,539.00. Following the transaction, the director now directly owns 59,406 shares in the company, valued at $5,645,352.18. The trade was a 2.14 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Exponent Stock Performance

Exponent stock opened at $95.05 on Thursday. Exponent, Inc. has a 1 year low of $68.70 and a 1 year high of $115.75. The firm’s 50-day moving average is $106.69 and its 200-day moving average is $102.09. The company has a market cap of $4.82 billion, a P/E ratio of 45.92 and a beta of 0.69.

Exponent Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Friday, December 6th will be issued a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a dividend yield of 1.18%. The ex-dividend date of this dividend is Friday, December 6th. Exponent’s dividend payout ratio (DPR) is presently 54.11%.

Institutional Trading of Exponent

Several hedge funds have recently made changes to their positions in EXPO. Westside Investment Management Inc. acquired a new stake in Exponent in the third quarter worth $26,000. Quarry LP acquired a new stake in shares of Exponent in the 2nd quarter worth about $25,000. GAMMA Investing LLC lifted its position in Exponent by 67.7% in the 2nd quarter. GAMMA Investing LLC now owns 379 shares of the business services provider’s stock valued at $36,000 after purchasing an additional 153 shares during the last quarter. Whittier Trust Co. of Nevada Inc. boosted its stake in Exponent by 166.5% during the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 517 shares of the business services provider’s stock valued at $49,000 after purchasing an additional 323 shares during the period. Finally, USA Financial Formulas bought a new position in Exponent in the 3rd quarter worth about $60,000. Institutional investors own 92.37% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Truist Financial reiterated a “buy” rating and issued a $120.00 target price (up previously from $100.00) on shares of Exponent in a research report on Friday, July 26th.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.